News

Ohio Lumex, a recognized leader in analytical solutions, is proud to announce a new partnership with German biotechnology company Dynamic42. Effective immediately, Ohio Lumex will serve as the exclusive distributor of Dynamic42’s innovative organ-on-chip technology in the United States.

Dynamic42 and Heinrich Heine University have developed a tumour-on-a-chip model that replicates the microenvironment of pancreatic ductal adenocarcinoma (PDAC). This 3D model allows for realistic drug testing and could accelerate the development of personalized therapies.

Dynamic42, in collaboration with ESQlabs, Bayer, and the Placenta Lab, has developed an innovative three-organ system with the potential to reduce animal testing in pharmaceutical research.

We were interviewed by the Ostthüringer Zeitung on the subject of animal-free research.

Dynamic42 has launched the “Online Academy” for learning Organ-on-Chip technology as an alternative to animal testing.

Improving people’s lives with innovative technologies. This was the goal that Jena-based Dynamic42 had in mind 18 months ago when they launched a project – funded as part of the Sanofi iDEA-iTECH Award Program.

The RUBIN alliance “ATHANA” met for their first strategy workshop one year after the project kicked off in summer last year.

We are excited to welcome Amélie Marie Paillereau to the Dynamic42 science team. Amélie started in April with us for a 12-month-long Master thesis, focusing on perfused breast and pancreatic cancer-on-chip models to study the impact of the tumor microenvironment on immune cell invasion.

We are delighted to announce that Joanna Nowacka has joined Dynamic42 as Lead for Stem Cell Model Development.

Dynamic42 has launched the “DynamicOrgan System”, an open, flexible, and cost-effective organ-on-chip platform for lab use.

We are delighted to announce that Marty Steiger has recently joined Dynamic42 as a applications specialist.

We are excited to announce that Mari Kakihara has joined us recently to support Finance and Controlling.

Dynamic42 GmbH has developed an intestine-on-chip candidiasis model that allows for the quantification of the infection process.

We are excited to announce that Japhette Kembou-Ringert has joined us at the beginning of this year to support our lab team.

Organ-on-chip specialist Dynamic42 GmbH and Biopredic, manufacturer of assay systems for research, announce a strategic Marketing agreement.

We are excited to announce that Noreen Schuck has joined us at the beginning of October to support our lab team.

The first 3R network meeting, organized by the Federal Ministry of Education and Research (BMBF) in Berlin, brought together various experts to discuss current developments, perspectives, and challenges in 3R research.

We are delighted to announce that Dr. Juliane Fischer has joined our team and will from now on heading all Marketing efforts at Dynamic42.

Following their Master’s studies, Daria and Sophie join our lab team as research assistants.

The RUBIN Alliance “ATHANA” (antifungal therapy approaches with nanoparticle-based targeting of drugs) is developing innovative therapeutic approaches for the treatment of infectious diseases, in particular fungal infections.

Innovative organ-on-chip specialist Dynamic42 GmbH has closed a mid-seven-figure financing round.

BC003: The special feature of the new chip is the spatial design with three culture chambers. This enables the cultivation of complex, three-dimensional tissue cultures.

A first-of-its-kind collaboration in the consumer health industry is developing a platform aimed at reducing or replacing animal testing using “organ-on-chip” (OoC) technology and interactive computational software.

Jena-based biotech company passes on expertise on future organ-on-chip technology to research institutions and companies

We were featured as a member of medways e.V. in Wirtschaftsspiegel.

In an interview with the trade journal “Laborjournal”, our managing directors explain how the Dynamic42 biotech chips work and how the “mini-organs” used contribute to reducing animal experiments.

An article in the MED Engineering journal explained the potential of our “mini organs” from the laboratory for drug and food testing.

Exciting answers to exciting questions: We were interviewed by bionity and analytica-world. Read it now!

Read the interview with Thomas Stölzel in WirtschaftsWoche.

Find out how our biotech chips are used in food analysis!

You want to know why we are called “Dynamic42”? Take a look at our feature on MDR Thüringen!

At the award ceremony for the XXIII Thuringian Innovation Prize, we were interviewed about our development for the Ostthüringer Zeitung newspaper.

Dynamic42 GmbH has closed a seven-figure start-up financing round – Read more about

We participate in the EU project to develop innovative model systems for the evaluation of immunomodulatory therapeutics.

The first seed financing in the six-figure range was closed in early summer 2019.

We were awarded the Thuringian Founder’s Prize 2018! We would like to thank everyone who made this possible for us!

We are at Medica in Düsseldorf – Come by and meet us!

Find out how our biotech chips are used in food analysis!

At the EY Public Value Award 2018, Dynamic42 GmbH was awarded the audience prize.